You can buy or sell Dynavax and other stocks, options, ETFs, and crypto commission-free!
Dynavax Technologies Corporation Common Stock, also called Dynavax, is a biopharmaceutical company, which engages in the development and discovery of novel vaccines and immuno-oncology therapeutics. It focuses on leveraging the body's innate and adaptive immune responses through toll-like receptor stimulation. Read More It offers products for vaccines, cancer immunotherapy, and immune-mediated diseases. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.
52 Week High
52 Week Low
Expected Nov 5, After Hours